Trial Profile
Neuroimaging study of panic disorder according to escitalopram treatment
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Escitalopram (Primary)
- Indications Panic disorder
- Focus Therapeutic Use
- 22 Jul 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 22 Jul 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 22 Jul 2011 Actual trial end date (Dec 2008) added as reported by ClinicalTrials.gov.